1‐Year radiosurgery‐targeted lesion controlNo. of participants: 602(4 RCTs) · patients with newly diagnosed multiple brain metastases
Radiosurgery alone leads to higher 1‐Year radiosurgery‐targeted lesion controlNo. of participants:… compared with WBRT and radiosurgery (high certainty).
1 finding from 1 review
HR 2.73 [1.87, 3.99]
Studies not reported
High
Surgically‐related severe adverse effects (grade 3+) ‐ stoma formation (within 30 days of surgery) · women with advanced ovarian epithelial cancer
Neoadjuvant chemotherapy prior to interval surgery (NACT) probably leads to lower surgically‐related severe adverse effects (grade 3+) ‐ stoma… compared with surgery followed by chemotherapy (PDS) (moderate certainty).
1 finding from 1 review
Surgically‐related severe adverse effects (grade 3+) ‐ bowel resection (within 30 days of surgery) · women with advanced ovarian epithelial cancer
Neoadjuvant chemotherapy prior to interval surgery (NACT) probably leads to lower surgically‐related severe adverse effects (grade 3+) ‐ bowel… compared with surgery followed by chemotherapy (PDS) (moderate certainty).
1 finding from 1 review
Surgically‐related severe adverse effects (grade 3+) ‐ postoperative G3+ events (within 30 days of surgery) · women with advanced ovarian epithelial cancer
Neoadjuvant chemotherapy prior to interval surgery (NACT) probably leads to lower surgically‐related severe adverse effects (grade 3+) ‐ postoperative… compared with surgery followed by chemotherapy (PDS) (moderate certainty).
1 finding from 1 review
Surgically‐related postoperative mortality (28 days to 6 months of surgery4) · women with advanced ovarian epithelial cancer
Neoadjuvant chemotherapy prior to interval surgery (NACT) leads to lower surgically‐related postoperative mortality (28 days to 6 months of… compared with surgery followed by chemotherapy (PDS) (high certainty).
1 finding from 1 review
Complete resection ‐ iMRI · high‐grade glioma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraoperative and postoperative complications · women undergoing hysterectomy
Robot‐assisted surgery showed no clear difference in intraoperative and postoperative complications compared with conventional laparoscopic surgery (low certainty).
1 finding from 1 review
Operating time · gynaecology
1 finding from 1 review
Length of hospital stay · gynaecology
1 finding from 1 review
Blood transfusion · gynaecology
The review found no eligible studies for this question.
1 finding from 1 review
Intraoperative complications · women undergoing hysterectomy
Robot‐assisted surgery showed no clear difference in intraoperative complications compared with conventional laparoscopic surgery (low certainty).
1 finding from 1 review
Postoperative complications · women undergoing hysterectomy
Robot‐assisted surgery showed no clear difference in postoperative complications compared with conventional laparoscopic surgery (low certainty).
1 finding from 1 review
Operating time · women undergoing hysterectomy
1 finding from 1 review
Length of hospital stay · women undergoing hysterectomy
1 finding from 1 review
Blood transfusion · women undergoing hysterectomy
Robot‐assisted surgery showed no clear difference in blood transfusions compared with conventional laparoscopic surgery (low certainty).
1 finding from 1 review
Intraoperative and postoperative complications · gynaecology
It is very uncertain whether robot‐assisted surgery changes intraoperative and postoperative complications compared with conventional laparoscopic surgery (very low certainty).
1 finding from 1 review
Intraoperative complications · gynaecology
It is very uncertain whether robot‐assisted surgery changes intraoperative complications compared with conventional laparoscopic surgery (very low certainty).
1 finding from 1 review
Postoperative complications · gynaecology
Robot‐assisted surgery may leads to higher postoperative complications compared with conventional laparoscopic surgery (low certainty).
1 finding from 1 review
Survival (overall and disease‐ specific) · women with stage IIIc or IV ovarian cancer
It is very uncertain whether ultra‐radical (extensive) surgery changes survival (overall and disease‐ specific) compared with standard surgery (very low certainty).
1 finding from 1 review
Progression‐free survival · women with stage IIIc or IV ovarian cancer
It is very uncertain whether ultra‐radical (extensive) surgery changes progression‐free survival compared with standard surgery (very low certainty).
1 finding from 1 review